Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoanalogues in chronic kidney disease
IRCT20230318057755N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Ketosteril in chronic kidney disease (CKD), sponsored by Shiraz University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
Ketosteril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20230318057755N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230318057755N1.